Literature DB >> 22889214

mTOR, metabolism, and the regulation of T-cell differentiation and function.

Adam T Waickman1, Jonathan D Powell.   

Abstract

Upon antigen recognition, naive T cells undergo rapid expansion and activation. The energy requirements for this expansion are formidable, and T-cell activation is accompanied by dramatic changes in cellular metabolism. Furthermore, the outcome of antigen engagement is guided by multiple cues derived from the immune microenvironment. Mammalian target of rapamycin (mTOR) is emerging as a central integrator of these signals playing a critical role in driving T-cell differentiation and function. Indeed, multiple metabolic programs are controlled by mTOR signaling. In this review, we discuss the role of mTOR in regulating metabolism and how these pathways intersect with the ability of mTOR to integrate cues that guide the outcome of T-cell receptor engagement.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889214      PMCID: PMC3419491          DOI: 10.1111/j.1600-065X.2012.01152.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  212 in total

1.  ICOS ligation recruits the p50alpha PI3K regulatory subunit to the immunological synapse.

Authors:  Camille Fos; Audrey Salles; Valérie Lang; Florent Carrette; Stéphane Audebert; Sonia Pastor; Marguerite Ghiotto; Daniel Olive; Georges Bismuth; Jacques A Nunès
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

2.  The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.

Authors:  Yasemin Sancak; Timothy R Peterson; Yoav D Shaul; Robert A Lindquist; Carson C Thoreen; Liron Bar-Peled; David M Sabatini
Journal:  Science       Date:  2008-05-22       Impact factor: 47.728

3.  Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling.

Authors:  Oak D Jo; Jheralyn Martin; Andrew Bernath; Janine Masri; Alan Lichtenstein; Joseph Gera
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

4.  Regulation of hypoxia-inducible factor 1 by glucose availability under hypoxic conditions.

Authors:  Jing Zhou; Kenta Hara; Masahiro Inoue; Suirin Hamada; Hisafumi Yasuda; Hiroaki Moriyama; Hiroko Endo; Kiichi Hirota; Kazuyoshi Yonezawa; Masao Nagata; Koichi Yokono
Journal:  Kobe J Med Sci       Date:  2008-02-08

5.  De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR.

Authors:  Johnthomas Kang; Stephen J Huddleston; Joanne M Fraser; Alexander Khoruts
Journal:  J Leukoc Biol       Date:  2008-02-12       Impact factor: 4.962

6.  AMPK phosphorylation of raptor mediates a metabolic checkpoint.

Authors:  Dana M Gwinn; David B Shackelford; Daniel F Egan; Maria M Mihaylova; Annabelle Mery; Debbie S Vasquez; Benjamin E Turk; Reuben J Shaw
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

7.  Regulation of TORC1 by Rag GTPases in nutrient response.

Authors:  Eunjung Kim; Pankuri Goraksha-Hicks; Li Li; Thomas P Neufeld; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

8.  T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.

Authors:  Stephan Sauer; Ludovica Bruno; Arnulf Hertweck; David Finlay; Marion Leleu; Mikhail Spivakov; Zachary A Knight; Bradley S Cobb; Doreen Cantrell; Eric O'Connor; Kevan M Shokat; Amanda G Fisher; Matthias Merkenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-28       Impact factor: 11.205

9.  The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells.

Authors:  Sokol Haxhinasto; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2008-02-18       Impact factor: 14.307

10.  SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.

Authors:  Thomas Porstmann; Claudio R Santos; Beatrice Griffiths; Megan Cully; Mary Wu; Sally Leevers; John R Griffiths; Yuen-Li Chung; Almut Schulze
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

View more
  179 in total

1.  Inflammatory IL-15 is required for optimal memory T cell responses.

Authors:  Martin J Richer; Lecia L Pewe; Lisa S Hancox; Stacey M Hartwig; Steven M Varga; John T Harty
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

2.  The differential roles of mTOR, ERK, and JNK pathways in invariant natural killer T-cell function and survival.

Authors:  Jun Tian; Li Liu; Xiangai Wang; Xuewu Sun; Suli Mu; Chuanjun Wu; Maoqiang Han
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

3.  Resveratrol attenuates stimulated T-cell activation and proliferation: potential therapy against cellular rejection in organ transplantation.

Authors:  Jimmy Jh Kang; Sabin J Bozso; Dana E Boe; David P Al-Adra; Michael C Moon; Darren H Freed; Jayan Nagendran; Jeevan Nagendran
Journal:  Am J Clin Exp Immunol       Date:  2020-12-15

4.  Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development.

Authors:  Po-Chien Chou; Won Jun Oh; Chang-Chih Wu; Joseph Moloughney; Markus A Rüegg; Michael N Hall; Estela Jacinto; Guy Werlen
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

Review 5.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 6.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 7.  Differential T-cell receptor signals for T helper cell programming.

Authors:  Penelope A Morel
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

8.  Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

Authors:  Hung D Nguyen; Shilpak Chatterjee; Kelley M K Haarberg; Yongxia Wu; David Bastian; Jessica Heinrichs; Jianing Fu; Anusara Daenthanasanmak; Steven Schutt; Sharad Shrestha; Chen Liu; Honglin Wang; Hongbo Chi; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

Review 9.  The obesity-related pathology and Th17 cells.

Authors:  Yusuke Endo; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Mol Life Sci       Date:  2016-10-18       Impact factor: 9.261

10.  The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.

Authors:  Andrew N Macintyre; Valerie A Gerriets; Amanda G Nichols; Ryan D Michalek; Michael C Rudolph; Divino Deoliveira; Steven M Anderson; E Dale Abel; Benny J Chen; Laura P Hale; Jeffrey C Rathmell
Journal:  Cell Metab       Date:  2014-06-12       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.